Treatment with SQ-HDM SLIT-tablet Improves Quality of Life in House Dust Mite Induced Allergic Rhinitis

Methods The RQLQ was included in three randomized, double-blinded, placebo-controlled clinical trials (P001, P003 and MT-06) evaluating the efficacy and safety of SQ HDM SLIT-tablet in North American and European subjects with HDM induced AR, with or without allergic asthma. Conclusions The RQLQ res...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2018-02, Vol.141 (2), p.AB164-AB164
Main Authors: Hammerby, Eva, Buchs, Sarah, Rance, Karen S., Rehm, Dorte
Format: Article
Language:English
Subjects:
Allergic rhinitis
Clinical trials
House dust
Mites
Nose
Quality of life
Rhinitis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page AB164
container_issue 2
container_start_page AB164
container_title Journal of allergy and clinical immunology
container_volume 141
creator Hammerby, Eva
Buchs, Sarah
Rance, Karen S.
Rehm, Dorte
description Methods The RQLQ was included in three randomized, double-blinded, placebo-controlled clinical trials (P001, P003 and MT-06) evaluating the efficacy and safety of SQ HDM SLIT-tablet in North American and European subjects with HDM induced AR, with or without allergic asthma. Conclusions The RQLQ results from three randomized, double-blinded, placebo-controlled clinical trials show that SQ HDM SLIT-tablet consistently improves the QoL of people suffering from HDM induced AR across slightly different populations and in different settings.
doi_str_mv 10.1016/j.jaci.2017.12.524
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2007521573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674917324247</els_id><sourcerecordid>2007521573</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1684-a11f340fc743f7f3a994b3f78d0dbffd36d9982f70494e314226232f89276343</originalsourceid><addsrcrecordid>eNp9kMtuwjAQRa2qlUppf6ArS10n9Ys4lrpB9AESqKKwt0IyBkchobZDxd_XiK67mhnp3pk7B6FHSlJKaPZcp3VR2pQRKlPK0hETV2hAiZJJlrPRNRoQomiSSaFu0Z33NYkzz9UAbdcOirCHNuAfG3Z4tUymrwu8ms_WSSg2DQQ82x9cdwSPl33R2HDCncFzawDbFk-73gN-7X3ACxsAz9qqL6HC46YBt7Ul_trZ1gbr79GNKRoPD391iNbvb-vJNJl_fswm43lS0iwXSUGp4YKYUgpupOGFUmITu7wi1caYimeVUjkzkgglgFPBWMY4M7liMuOCD9HTZW2M_N2DD7ruetfGi5oRIkeMjiSPKnZRla7z3oHRB2f3hTtpSvSZp671mac-89SU6cgzml4uJojxjxac9qWFNn5rHZRBV539z_4LHnd8Vg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007521573</pqid></control><display><type>article</type><title>Treatment with SQ-HDM SLIT-tablet Improves Quality of Life in House Dust Mite Induced Allergic Rhinitis</title><source>ScienceDirect Journals</source><creator>Hammerby, Eva ; Buchs, Sarah ; Rance, Karen S. ; Rehm, Dorte</creator><creatorcontrib>Hammerby, Eva ; Buchs, Sarah ; Rance, Karen S. ; Rehm, Dorte</creatorcontrib><description>Methods The RQLQ was included in three randomized, double-blinded, placebo-controlled clinical trials (P001, P003 and MT-06) evaluating the efficacy and safety of SQ HDM SLIT-tablet in North American and European subjects with HDM induced AR, with or without allergic asthma. Conclusions The RQLQ results from three randomized, double-blinded, placebo-controlled clinical trials show that SQ HDM SLIT-tablet consistently improves the QoL of people suffering from HDM induced AR across slightly different populations and in different settings.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2017.12.524</identifier><language>eng</language><publisher>St. Louis: Elsevier Inc</publisher><subject>Allergic rhinitis ; Clinical trials ; House dust ; Mites ; Nose ; Quality of life ; Rhinitis</subject><ispartof>Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB164-AB164</ispartof><rights>2017</rights><rights>Copyright Elsevier Science Ltd. Feb 1, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Hammerby, Eva</creatorcontrib><creatorcontrib>Buchs, Sarah</creatorcontrib><creatorcontrib>Rance, Karen S.</creatorcontrib><creatorcontrib>Rehm, Dorte</creatorcontrib><title>Treatment with SQ-HDM SLIT-tablet Improves Quality of Life in House Dust Mite Induced Allergic Rhinitis</title><title>Journal of allergy and clinical immunology</title><description>Methods The RQLQ was included in three randomized, double-blinded, placebo-controlled clinical trials (P001, P003 and MT-06) evaluating the efficacy and safety of SQ HDM SLIT-tablet in North American and European subjects with HDM induced AR, with or without allergic asthma. Conclusions The RQLQ results from three randomized, double-blinded, placebo-controlled clinical trials show that SQ HDM SLIT-tablet consistently improves the QoL of people suffering from HDM induced AR across slightly different populations and in different settings.</description><subject>Allergic rhinitis</subject><subject>Clinical trials</subject><subject>House dust</subject><subject>Mites</subject><subject>Nose</subject><subject>Quality of life</subject><subject>Rhinitis</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kMtuwjAQRa2qlUppf6ArS10n9Ys4lrpB9AESqKKwt0IyBkchobZDxd_XiK67mhnp3pk7B6FHSlJKaPZcp3VR2pQRKlPK0hETV2hAiZJJlrPRNRoQomiSSaFu0Z33NYkzz9UAbdcOirCHNuAfG3Z4tUymrwu8ms_WSSg2DQQ82x9cdwSPl33R2HDCncFzawDbFk-73gN-7X3ACxsAz9qqL6HC46YBt7Ul_trZ1gbr79GNKRoPD391iNbvb-vJNJl_fswm43lS0iwXSUGp4YKYUgpupOGFUmITu7wi1caYimeVUjkzkgglgFPBWMY4M7liMuOCD9HTZW2M_N2DD7ruetfGi5oRIkeMjiSPKnZRla7z3oHRB2f3hTtpSvSZp671mac-89SU6cgzml4uJojxjxac9qWFNn5rHZRBV539z_4LHnd8Vg</recordid><startdate>201802</startdate><enddate>201802</enddate><creator>Hammerby, Eva</creator><creator>Buchs, Sarah</creator><creator>Rance, Karen S.</creator><creator>Rehm, Dorte</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>201802</creationdate><title>Treatment with SQ-HDM SLIT-tablet Improves Quality of Life in House Dust Mite Induced Allergic Rhinitis</title><author>Hammerby, Eva ; Buchs, Sarah ; Rance, Karen S. ; Rehm, Dorte</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1684-a11f340fc743f7f3a994b3f78d0dbffd36d9982f70494e314226232f89276343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Allergic rhinitis</topic><topic>Clinical trials</topic><topic>House dust</topic><topic>Mites</topic><topic>Nose</topic><topic>Quality of life</topic><topic>Rhinitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hammerby, Eva</creatorcontrib><creatorcontrib>Buchs, Sarah</creatorcontrib><creatorcontrib>Rance, Karen S.</creatorcontrib><creatorcontrib>Rehm, Dorte</creatorcontrib><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hammerby, Eva</au><au>Buchs, Sarah</au><au>Rance, Karen S.</au><au>Rehm, Dorte</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment with SQ-HDM SLIT-tablet Improves Quality of Life in House Dust Mite Induced Allergic Rhinitis</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2018-02</date><risdate>2018</risdate><volume>141</volume><issue>2</issue><spage>AB164</spage><epage>AB164</epage><pages>AB164-AB164</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Methods The RQLQ was included in three randomized, double-blinded, placebo-controlled clinical trials (P001, P003 and MT-06) evaluating the efficacy and safety of SQ HDM SLIT-tablet in North American and European subjects with HDM induced AR, with or without allergic asthma. Conclusions The RQLQ results from three randomized, double-blinded, placebo-controlled clinical trials show that SQ HDM SLIT-tablet consistently improves the QoL of people suffering from HDM induced AR across slightly different populations and in different settings.</abstract><cop>St. Louis</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jaci.2017.12.524</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB164-AB164
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_journals_2007521573
source ScienceDirect Journals
subjects Allergic rhinitis
Clinical trials
House dust
Mites
Nose
Quality of life
Rhinitis
title Treatment with SQ-HDM SLIT-tablet Improves Quality of Life in House Dust Mite Induced Allergic Rhinitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T01%3A43%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20with%20SQ-HDM%20SLIT-tablet%20Improves%20Quality%20of%20Life%20in%20House%20Dust%20Mite%20Induced%20Allergic%20Rhinitis&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Hammerby,%20Eva&rft.date=2018-02&rft.volume=141&rft.issue=2&rft.spage=AB164&rft.epage=AB164&rft.pages=AB164-AB164&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2017.12.524&rft_dat=%3Cproquest_cross%3E2007521573%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1684-a11f340fc743f7f3a994b3f78d0dbffd36d9982f70494e314226232f89276343%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2007521573&rft_id=info:pmid/&rfr_iscdi=true